With the spread of the new coronavirus variant strain Omicron, many countries are widely using COVID-19 self test reagent kits. This kind of testing kits that can be tested at home and the results can be known immediately were once in short supply. There are many rapid antigen test kits for the new crown are made in China, also the testing sensitivity is very stable. In response to the surge in cases caused by the mutant strain of Omicron, the U.S. government recently purchased 1 billion rapid test kits for the new crown and provided them to Americans for free. "500 million COVID-19 rapid test kits will be available to order on January 19 and will be mailed directly to American families," the White House said in a statement. The statement also said that to make the self test reagent kits available to more people, every address will be able to apply for four COVID-19 rapid test kits. Kits typically ship within 7 to 12 days of ordering. The UK is also making extensive use of rapid tests (lateral flow tests), the BBC said in a January report, following documents revealing that the UK government plans to use millions of cheap, one-off tests. Lateral flow tests, which give results within 15 minutes, but PCR tests must be sent out and processed in a lab. These rapid lateral flow tests have gradually become part of everyday life in the UK. In the 2021-2022 financial year, £4.7 billion will be spent on large-scale rapid testing in the UK. In Australia, the new rapid antigen self test reagent kit has even become a hard-to-get product. Prime Minister Scott Morrison also told Australia's 2GB radio station in mid-January: "There is a shortage of rapid test kits around the world. This is not unique to Australia." The Science and Technology Daily, the official newspaper of China's Ministry of Science and Technology, reported that customs data showed that in November 2021, China's antigen detection reagents were mainly sold to the United States, Britain, Germany, Canada, and Greece. Although these "Made in China" rapid test kits for the new coronavirus have traveled across the ocean and helped billion of people. PureFDA a global regulatory medical device consulting company which provides expert advice on global regulatory requirements for medical devices. Our complete solution will give you the support you need until you have met regulatory compliance requirements prior to commercial distribution worldwide.